CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers.
;
Sarah Maguire;
Anna Morra;
Pooja Middha Kapoor ;
Katarzyna Tomczyk;
Michael E Jones;
Minouk J Schoemaker;
Clare Gilham ;
Manjeet K Bolla;
Qin Wang;
+142 more...
Joe Dennis ;
Thomas U Ahearn;
Irene L Andrulis;
Hoda Anton-Culver;
Natalia N Antonenkova;
Volker Arndt;
Kristan J Aronson;
Annelie Augustinsson;
Caroline Baynes;
Laura E Beane Freeman;
Matthias W Beckmann;
Javier Benitez;
Marina Bermisheva;
Carl Blomqvist;
Bram Boeckx;
Natalia V Bogdanova;
Stig E Bojesen;
Hiltrud Brauch;
Hermann Brenner ;
Barbara Burwinkel;
Daniele Campa;
Federico Canzian ;
Jose E Castelao;
Stephen J Chanock;
Georgia Chenevix-Trench;
Christine L Clarke;
NBCS Collaborators;
Don M Conroy;
Fergus J Couch;
Angela Cox ;
Simon S Cross;
Kamila Czene;
Thilo Dörk;
A Heather Eliassen;
Christoph Engel;
D Gareth Evans;
Peter A Fasching ;
Jonine Figueroa;
Giuseppe Floris;
Henrik Flyger;
Manuela Gago-Dominguez;
Susan M Gapstur;
Montserrat García-Closas;
Mia M Gaudet;
Graham G Giles;
Mark S Goldberg;
Anna González-Neira;
AOCS Group;
Pascal Guénel;
Eric Hahnen;
Christopher A Haiman;
Niclas Håkansson;
Per Hall;
Ute Hamann;
Patricia A Harrington;
Steven N Hart ;
Maartje J Hooning;
John L Hopper;
Anthony Howell;
David J Hunter;
ABCTB Investigators;
kConFab Investigators;
Agnes Jager;
Anna Jakubowska ;
Esther M John;
Rudolf Kaaks;
Renske Keeman;
Elza Khusnutdinova;
Cari M Kitahara;
Veli-Matti Kosma;
Stella Koutros;
Peter Kraft;
Vessela N Kristensen;
Allison W Kurian ;
Diether Lambrechts;
Loic Le Marchand;
Martha Linet;
Jan Lubiński;
Arto Mannermaa;
Siranoush Manoukian;
Sara Margolin;
John WM Martens;
Dimitrios Mavroudis;
Rebecca Mayes;
Alfons Meindl;
Roger L Milne;
Susan L Neuhausen;
Heli Nevanlinna;
William G Newman;
Sune F Nielsen;
Børge G Nordestgaard;
Nadia Obi;
Andrew F Olshan;
Janet E Olson;
Håkan Olsson;
Ester Orban;
Tjoung-Won Park-Simon;
Paolo Peterlongo ;
Dijana Plaseska-Karanfilska;
Katri Pylkäs;
Gad Rennert;
Hedy S Rennert;
Kathryn J Ruddy;
Emmanouil Saloustros;
Dale P Sandler;
Elinor J Sawyer ;
Rita K Schmutzler;
Christopher Scott;
Xiao-Ou Shu;
Jacques Simard;
Snezhana Smichkoska;
Christof Sohn;
Melissa C Southey;
John J Spinelli;
Jennifer Stone;
Rulla M Tamimi;
Jack A Taylor;
Rob AEM Tollenaar;
Ian Tomlinson ;
Melissa A Troester;
Thérèse Truong ;
Celine M Vachon;
Elke M van Veen;
Sophia S Wang;
Clarice R Weinberg;
Camilla Wendt;
Hans Wildiers;
Robert Winqvist;
Alicja Wolk;
Wei Zheng;
Argyrios Ziogas;
Alison M Dunning;
Paul DP Pharoah ;
Douglas F Easton;
A Forbes Howie;
Julian Peto ;
Isabel Dos-Santos-Silva ;
Anthony J Swerdlow;
Jenny Chang-Claude;
Marjanka K Schmidt;
Nick Orr;
Olivia Fletcher;
(2021)
CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers.
British journal of cancer, 124 (4).
pp. 842-854.
ISSN 0007-0920
DOI: 10.1038/s41416-020-01185-w
BACKGROUND: Epidemiological studies provide strong evidence for a role of endogenous sex hormones in the aetiology of breast cancer. The aim of this analysis was to identify genetic variants that are associated with urinary sex-hormone levels and breast cancer risk. METHODS: We carried out a genome-wide association study of urinary oestrone-3-glucuronide and pregnanediol-3-glucuronide levels in 560 premenopausal women, with additional analysis of progesterone levels in 298 premenopausal women. To test for the association with breast cancer risk, we carried out follow-up genotyping in 90,916 cases and 89,893 controls from the Breast Cancer Association Consortium. All women were of European ancestry. RESULTS: For pregnanediol-3-glucuronide, there were no genome-wide significant associations; for oestrone-3-glucuronide, we identified a single peak mapping to the CYP3A locus, annotated by rs45446698. The minor rs45446698-C allele was associated with lower oestrone-3-glucuronide (-49.2%, 95% CI -56.1% to -41.1%, P = 3.1 × 10-18); in follow-up analyses, rs45446698-C was also associated with lower progesterone (-26.7%, 95% CI -39.4% to -11.6%, P = 0.001) and reduced risk of oestrogen and progesterone receptor-positive breast cancer (OR = 0.86, 95% CI 0.82-0.91, P = 6.9 × 10-8). CONCLUSIONS: The CYP3A7*1C allele is associated with reduced risk of hormone receptor-positive breast cancer possibly mediated via an effect on the metabolism of endogenous sex hormones in premenopausal women.
-
picture_as_pdf - s41416-020-01185-w.pdf
-
subject - Published Version
-
- Available under Creative Commons: NC-ND 3.0